The International Monetary Fund believes that most of the impact from tighter money policies has already affected the U.S. economy, with the rest expected this year. Despite worries about a recession, the U.S. has shown resilience and strong growth since interest rates started going up in March 2022. This suggests a positive outlook for the U.S. economy in the coming months.
With our economy looking to perform well this year, you need to invest in these biotech stocks that will provide high returns this year, with their new advances.
This post appeared first on InvestorPlace.